Synthesis and in vitro modeling and characterization of self-assembling drug conjugates for targeted medicinal application.
A number of conjugates tend to self-associate in a transient or permanent fashion and this has formed the basis of considerable intense scientific and commercial investigation over recent years. This article considers a variety of strategic formulations, their flaws and advantages. Working practices and groundbreaking developmental activities within the sphere of self-assembling drug conjugates are also reviewed.
Sarker
D K
DK
Interfacial Nanotechnology Group, School of Pharmacy and Biomolecular Sciences, The University of Brighton, Brighton BN2 4GJ, UK. d.k.sarker@brighton.ac.uk
D002626:Chemistry, Pharmaceutical; D016503:Drug Delivery Systems / Q000379:methods*; D015195:Drug Design; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000737:chemistry*
D004364:Pharmaceutical Preparations